Biomedical news
Delta plus AY.4.2 variant and the level of risk of COVID disease spread
Corona virus is a large family of viruses that includes many strains of viruses that affect the respiratory system of mammals, including humans.
FDA approves Byooviz
September 17, 2021 The US Food and Drug Administration (FDA) has announced the approval of Byooviz (ranibizumab-nuna) as the first biosimilar of Lcentis (ranibizumab).
Vitro fertilization babies can grow well too!
Many people believe that children conceived through in vitro fertilization (IVF) will not be at risk of birth defects, because they are made up of selected eggs and sperm. But that is not the case, "vitro fertilization babies" are still at risk of birth defects for many different reasons.
2021 through the vision of genetics
Genome research and applications are playing an irreplaceably important role in fighting the pandemic. And this year's breakthroughs will continue to improve human health against more than just Covid. Below are some of our achievements in the field of genetics.
The truth about Omicron? What scientists know so far
COVID researchers are working at breakneck speed to learn about the variant's transmissibility, severity and ability to evade vaccines.
ctDNA: A novel adjuvant biomarker in resectable solid tumors
Circulating tumor DNA secreted into the blood by tumors has been shown to be a potent liquid biomarker for cancer.
CRISPR - A new route to produce antibiotics
New methods are urgently needed to develop new antibiotics. Now, scientists have developed a way to manipulate key assembly line enzymes in bacteria, using CRISPR-Cas9 gene editing, which could pave the way for the production of a generation of complex new antibiotics.
